185750.KS
185750.KS
KR7185750007
CHONGKUNDANG
Loading chart...

Company Profile

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Related stocks

003850.KS
003850.KS • South Korea
Boryung
8,610 KRW
525.24M USD 1Y +0.2%
069620.KS
069620.KS • South Korea
DAEWOONG PHARM
108,500 KRW
931.65M USD 1Y -18.3%
195940.KQ
195940.KQ • South Korea
HK inno.N
39,700 KRW
839.31M USD 1Y -13.3%
300485.SZ
300485.SZ • China
SCIENCE SUN
8.57 CNY
617.67M USD 1Y -24%
300194.SZ
300194.SZ • China
FUAN PHARM
4.03 CNY
717.42M USD 1Y -7.8%
4123.TWO
4123.TWO • Taiwan
CENTER LABORATORIES INC
31.35 TWD
735.36M USD 1Y -5.4%
603567.SS
603567.SS • China
HEILONGJIANG ZBD PHARMACEUTICAL
5.4 CNY
759.73M USD 1Y -53.4%
006280.KS
006280.KS • South Korea
GC Biopharma Corp.
129,400 KRW
1.1B USD 1Y -2.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.4% p.a.
Max Drawdown (5Y)
-49.6%
Sharpe Ratio (5Y)
-0.30
Beta Factor
0.24
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (37.8%) is noticeably higher than the 5Y average (33.4%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -69.2% in the extended horizon.
ende